Audrey Kauffmann
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Fibroblast Growth Factor Research, Pancreatic and Hepatic Oncology Research, PI3K/AKT/mTOR signaling in cancer, Single-cell and spatial transcriptomics
Most-Cited Works
- → Next-generation characterization of the Cancer Cell Line Encyclopedia(2019)3,622 cited
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → arrayQualityMetrics—a bioconductor package for quality assessment of microarray data(2008)973 cited
- → Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening(2017)693 cited
- → Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials(2014)491 cited
- → Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity(2010)452 cited